Not logged in.png)
Share.png)
SaveShare Save Discovery of (E)-2-cyano-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-3-(1H-indol-3-yl)acrylamide as a novel TDO inhibitor for cancer treatment
Wang, Xiang; Wang, Xiaoshuang; Wang, Xiaoxue; Xu, Kejia; Long, Jie; Chen, Yanan; Liu, Yanhua; Niu, Haiying; Zeng, Beilei; Fan, Yan Share Save Share Save Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cellsJiang, Qinglian; Chi, Xuyang; Wei, Tong; Nakayamada, Shingo; Shan, Yu; Sun, Yini; Zhao, Xing; Zhou, Jieqing; Fan, Yan; Gu, Jia; Jiang, Hong; Ma, Xiaoxue Share Save Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancerWang, Xiaoxue; Qin, Zhongxiang; Qiu, Wenrui; Xu, Kejia; Bai, Yuting; Zeng, Beilei; Ma, Yakun; Yang, Shuang; Shi, Yi; Fan, Yan Share Save Share Save Share Save Share Save Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4DFang, Zhen; Liu, Yang; Zhang, Rong; Chen, Qiang; Wang, Tianqi; Yang, Wei; Fan, Yan; Yu, Chundong; Xiang, Rong; Yang, Shengyong Share Save Share Save Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription controlWang, Xin; Deng, Kaiyuan; Wang, Cheng; Li, Yao; Wang, Tianqi; Huang, Zhi; Ma, Yakun; Sun, Peiqing; Shi, Yi; Yang, Shengyong; Fan, Yan; Xiang, Rong Share Save Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesisHuang, Zhi; Zhao, Borui; Qin, Zhongxiang; Li, Yongtao; Wang, Tianqi; Zhou, Wei; Zheng, Jianyu; Yang, Shengyong; Shi, Yi; Fan, Yan; Xiang, Rong Share Save Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer sternness activity against non-small-cell lung cancerWang, Xin; Yu, Chenhua; Wang, Cheng; Ma, Yakun; Wang, Tianqi; Li, Yao; Huang, Zhi; Zhou, Mangian; Sun, Peiqing; Zheng, Jianyu; Yang, Shengyong; Fan, Yan; Xiang, Rong Share Save Share Save Share Save Share Save Share Save Discovery of &ITN&IT1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7&ITH&IT-pyrrolo[2,3-&ITd&IT]pyrimidin-2-yl)amino)phenyl)-&ITN&IT8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase 1 (HDAC1) against Malignant CancerLi, Yongtao; Luo, Xiaohe; Guo, Qingxiang; Nie, Yongwei; Wang, Tianqi; Zhang, Chao; Huang, Zhi; Wang, Xin; Liu, Yanhua; Chen, Yanan; Zheng, Jianyu; Yang, Shengyong; Fan, Yan; Xiang, Rong Share Save Highly Selective, Potent, and Oral mTOR Inhibitor for Treatment of Cancer as Autophagy InducerGuo, Qingxiang; Yu, Chenhua; Zhang, Chao; Li, Yongtao; Wang, Tianqi; Huang, Zhi; Wang, Xin; Zhou, Wei; Li, Yao; Qin, Zhongxiang; Wang, Cheng; Gao, Ruifang; Nie, Yongwei; Ma, Yakun; Shi, Yi; Zheng, Jianyu; Yang, Shengyong; Fan, Yan; Xiang, Rong Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
